Katharina Hohenwallner

发表

Decoding Distinct Ganglioside Patterns of Native and Differentiated Mesenchymal Stem Cells by a Novel Glycolipidomics Profiling Strategy

J. Hartler, G. Koellensperger, C. Kasper, 2022, bioRxiv.

The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation

C. Pirker, T. Mohr, W. Berger, 2022, Pharmaceutics.

Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands

W. Berger, J. Kopecka, C. Riganti, 2021, Journal of medicinal chemistry.

A Taxonomically-informed Mass Spectrometry Search Tool for Microbial Metabolomics Data

Sara L. Jackrel, Emily C. Gentry, Allegra T. Aron, 2023, bioRxiv.